Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Novel PDE5 inhibitor for erectile dysfunction by Schering Plough

March 29, 2004

Merck to discontinue development of EMR-62203

March 29, 2004

Fosrenol receives approval in Sweden

March 26, 2004

NM-100061 produces positive results in early ejaculation study

March 25, 2004

Antares' topical oxybutynin product successfully completes phase I trial

March 19, 2004

Milestone achievements and patient treatment with Prolieve

March 16, 2004

GSK presents four related series of ALK5 inhibitors

March 16, 2004

Nippon Kayaku reports in vivo effects of NK-082411 on micturition

March 12, 2004

Patient, physician satisfaction with Levitra

March 12, 2004

Four new SOAR collaborations for KRX-101

March 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...